ID: h-a0bd8d4f4c
Hypothesis
Reactive astrocyte glutamate-handling failure sustains dendritic tau-associated excitotoxic stress after Aβ clearance
Aβ leaves astrocytes in a reactive, low-EAAT2 state that increases extrasynaptic NMDA receptor drive, allowing dendritic tau to keep amplifying excitotoxic signaling without ongoing amyloid.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 7 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Aβ leaves astrocytes in a reactive, low-EAAT2 state that increases extrasynaptic NMDA receptor drive, allowing dendritic tau to keep amplifying excitotoxic signaling without ongoing amyloid. This is a plausible circuit-level modifier mechanism but currently lacks direct evidence as the core persistence driver.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Amyloid-beta Oligomers<br/>Synaptic/Extrasynaptic"]
B["Extrasynaptic GRIN2B-NMDAR<br/>Aberrant Activation"]
C["Calcineurin Activation<br/>Sustained Ca2+ Entry"]
D["AMPAR Endocytosis<br/>Synaptic Depression"]
E["CREB Inactivation<br/>Reduced BDNF Expression"]
F["Synaptic Weakening<br/>LTP Impairment"]
G["Memory Encoding Deficit<br/>Cognitive Decline"]
A --> B
B --> C
C --> D
C --> E
D --> F
E --> F
F --> G
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix7 supports2 contradicts
Supports
Tau-linked excitotoxic vulnerability and Aβ-induced synaptic dysfunction make a neuron-astrocyte persistence circuit plausible.
Supports
Aβ oligomers induce tau missorting and calcium dysregulation, compatible with a glutamate-clearance amplifier.
Supports
Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App(NL-G-F) Knock-in Mice.
Supports
High-altitude hypoxia drives dentate gyrus neuronal vulnerability through an IL1α-astrocyte-SLC1A2 pathway.
Supports
Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.
Supports
EAAT2 dysfunction mediates acrylamide-induced excitotoxicity and neuronal damage in a SH-SY5Y/U251 co-culture model.
Contradicts
Direct evidence for the sequence transient Aβ to lasting EAAT2 failure to persistent tau missorting is weak.
Contradicts
Replacing astrocytes after Aβ washout could plausibly leave neuronal tau pathology unchanged, arguing against astrocytes being required for persistence.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — SLC1A2
No curated PDB or AlphaFold mapping for SLC1A2 yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for SLC1A2,GRIN2B,MAPT from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SLC1A2,GRIN2B,MAPT.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0158
Events (7d)
0
Price History
▲2.8%💾 Resource Usage
LLM Tokens
17,362
$0.0521
Total Cost
$0.0521
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF EAAT2 (SLC1A2) expression and function are restored in reactive astrocytes using AAV9-mediated gene delivery in 5xFAD mice at 6 months post-Aβ immunization, THEN hippocampal dendritic tau phosphory | Significant reduction in phospho-tau (Thr231) and GRIN2B surface expression in hippocampal dendritic compartments | — no observation — | pending | 0.65 |
| IF extrasynaptic NMDA receptor subunit GRIN2B is selectively inhibited with a targeted antagonist (e.g., UHD, 10 mg/kg/day) in APP/PS1dE9 mice starting 4 weeks after Aβ immunotherapy completion, THEN | Reduced cortical neuronal degeneration (NeuN+ cell count) and lower CSF total tau and phospho-tau (Thr181) concentrations | — no observation — | pending | 0.60 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF EAAT2 (SLC1A2) expression and function are restored in reactive astrocytes using AAV9-mediated gene delivery in 5xFAD mice at 6 months post-Aβ immunization, THEN hippocampal dendritic tau phosphorylation at Thr231 and extrasynaptic NMDA receptor surface expression will decrease by ≥40% compared t
Predicted outcome: Significant reduction in phospho-tau (Thr231) and GRIN2B surface expression in hippocampal dendritic compartments
Falsification: EAAT2 restoration produces no significant change (<15%) in tau phosphorylation or extrasynaptic NMDAR expression despite confirmed EAAT2 overexpression and functional glutamate uptake activity
pendingconf 60%
IF extrasynaptic NMDA receptor subunit GRIN2B is selectively inhibited with a targeted antagonist (e.g., UHD, 10 mg/kg/day) in APP/PS1dE9 mice starting 4 weeks after Aβ immunotherapy completion, THEN rates of cortical neuron loss and CSF tau levels will decrease by ≥35% compared to vehicle-treated i
Predicted outcome: Reduced cortical neuronal degeneration (NeuN+ cell count) and lower CSF total tau and phospho-tau (Thr181) concentrations
Falsification: GRIN2B inhibition fails to significantly alter neuron counts or CSF tau levels (<20% change) compared to vehicle, despite confirmed target engagement and Aβ clearance confirmed by ELISA
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.